Health & ScienceBiotechnology
China Approves World's First CAR-T Therapy for Solid Tumors
China's NMPA approved satri-cel, the world's first CAR-T therapy for solid tumors, targeting advanced gastric cancer at 990,000 yuan per infusion.
—5 min read
Tag
2 articles
China's NMPA approved satri-cel, the world's first CAR-T therapy for solid tumors, targeting advanced gastric cancer at 990,000 yuan per infusion.
Four-year-old Kasper needs €315,000 CAR-T therapy in Rome, not reimbursed in Belgium. His family's crowdfunding highlights gaps in cancer care.